In the recent times, Indian pharmaceutical industry has been facing quality issues with the US Food & Drug Administration (FDA), with the US drug regulator issuing import alert, warning letters or observations under 483 Form to many of the leading Indian pharma companies. To overcome quality issues in the industry, technologies such as Internet of Things (IoT) can prove to be handy, says an Assocham-Sathguru joint study.
The increasing frequency of the US FDA inspections in India and the upward trend in warning letters has put the industry in a panic drive. “In an export driven market, where credibility weighs high